Anellovirus protein encoded by <i>ORF2/3</i> functions as the viral replication initiation protein
Abstract
Anelloviridae is a family of single-stranded DNA viruses that are thought to be nonpathogenic and commensal. Despite their ubiquitous presence in human populations, little is known about the anellovirus mechanism of replication in host cells. We identified the protein coded by ORF2/3 as necessary and sufficient to initiate replication from the minimal origin of replication for viruses of both the Beta- and Alphatorquevirus genera. Supporting this observation, we identified components of the polymerase alpha and BTR (Bloom’s syndrome helicase (BLM), topoisomerase IIIα, RMI1, and RMI2) complexes as interacting with the viral replication initiation protein (Rip) during DNA replication, suggesting a recombination-dependent mechanism of replication that uses host cell machinery to mediate dissolution of replication intermediates. Furthermore, we mapped a 92-bp minimal origin of replication sequence for the Betatorquevirus genus composed of an adenine and thymine (AT)-rich stretch and a portion of the guanine and cytosine (GC)-rich region. Altogether, this study provides insight into the mechanism by which anelloviruses manipulate host cell machinery to facilitate viral genome replication and represents a significant step forward in understanding the complex processes underlying anellovirus replication and persistent infection of these important commensal viruses.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (13)
Nicole Boisvert
Ring Therapeutics
Stephanie Thurmond
Ring Therapeutics
Carmen Elenberger
Ring Therapeutics
Patricio Jeraldo
Ring Therapeutics
Cato Prince
Ring Therapeutics
Nolan Sutherland
Ring Therapeutics
José Melo
Ring Therapeutics
Ken Tsheowang
Ring Therapeutics
Cameron Dodier
Ring Therapeutics
Maciej Nogalski
Ring Therapeutics
Dinesh Verma
Ring Therapeutics
Geoffrey Parsons
Ring Therapeutics
Joseph Cabral
Ring Therapeutics